Popular

Skin Barrier Maintenance in Atopic Dermatitis and Psoriasis
Practical DermatologySkin Barrier Maintenance in Atopic Dermatitis and Psoriasis

Potential Impact of Aryl Hydrocarbon Activation on Pigment
Practical DermatologyPotential Impact of Aryl Hydrocarbon Activation on Pigment

Mechanism of Action for Aryl Hydrocarbon Receptor Agonists
Practical DermatologyMechanism of Action for Aryl Hydrocarbon Receptor Agonists

Various Benefits of Aryl Hydrocarbon Receptor Agonists
Practical DermatologyVarious Benefits of Aryl Hydrocarbon Receptor Agonists

Antihistamine Selection and Measuring Disease Control in Chronic Spontaneous Urticaria
Practical DermatologyAntihistamine Selection and Measuring Disease Control in Chronic Spontaneous Urticaria
Programs

Understanding BTK Inhibition in Chronic Spontaneous Urticaria
Practical DermatologyUnderstanding BTK Inhibition in Chronic Spontaneous Urticaria

Managing Patient Expectations with Topical Therapies
Practical DermatologyManaging Patient Expectations with Topical Therapies

Antihistamine Selection and Measuring Disease Control in Chronic Spontaneous Urticaria
Practical DermatologyAntihistamine Selection and Measuring Disease Control in Chronic Spontaneous Urticaria

ADORING Trials Show Broad Efficacy, Early Itch Relief
Practical DermatologyADORING Trials Show Broad Efficacy, Early Itch Relief

Why Lower-Frequency Dosing Can Be Helpful in Atopic Dermatitis
Practical DermatologyWhy Lower-Frequency Dosing Can Be Helpful in Atopic Dermatitis
Clinical Practice

Translating Nonsteroidal MRA Evidence Into Practice: Optimizing Cardiorenal Outcomes in Patients With CKD
CME/CETranslating Nonsteroidal MRA Evidence Into Practice: Optimizing Cardiorenal Outcomes in Patients With CKD

Translating Evidence Into Practice: Myosin Inhibition Across the HCM Spectrum
CME/CETranslating Evidence Into Practice: Myosin Inhibition Across the HCM Spectrum

Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs
MinuteCE®Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs

The New Era of Targeted Therapy for Myasthenia Gravis
NeuroFrontiersThe New Era of Targeted Therapy for Myasthenia Gravis

Key Takeaways From the SMART Trial's 3-Year Women's Subgroup Analysis
CardiologyKey Takeaways From the SMART Trial's 3-Year Women's Subgroup Analysis

INFINITY in Focus: Translating New Nonsteroidal MRA Evidence Into Cardiorenal Practice
NephrologyINFINITY in Focus: Translating New Nonsteroidal MRA Evidence Into Cardiorenal Practice
Doctors Lounge

Earlier Detection, Smarter Prevention: AI-Powered Alzheimer's Care
The ConvergenceEarlier Detection, Smarter Prevention: AI-Powered Alzheimer's Care

Advancing ATTR-CM Identification: Early Findings from TRACE-AI
Heart MattersAdvancing ATTR-CM Identification: Early Findings from TRACE-AI

The Science of Exceptions: Setting the Safety Bar for Clinical AI
The ConvergenceThe Science of Exceptions: Setting the Safety Bar for Clinical AI

Maintaining Weight Loss: Early Evidence on Microbiome-Derived Supplementation
NutritionEdgeMaintaining Weight Loss: Early Evidence on Microbiome-Derived Supplementation
CME

Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
CME/CEEngineering Safer Antithrombotic Strategies for Secondary Stroke Prevention

Sticking Points: Managing Injection Site Reactions From Long-Acting Injectable Medications for HIV Care
CME/CESticking Points: Managing Injection Site Reactions From Long-Acting Injectable Medications for HIV Care

Individualizing Management Strategies for PSVT: Incorporating Patient Preference
MinuteCE®Individualizing Management Strategies for PSVT: Incorporating Patient Preference

Recurrence as the Rule: BD Symptoms Persist and Cycle
MinuteCE®Recurrence as the Rule: BD Symptoms Persist and Cycle

Secondary Stroke Prevention in Focus: Addressing Residual Thrombotic Risk
CME/CE Broadcast ReplaySecondary Stroke Prevention in Focus: Addressing Residual Thrombotic Risk

Navigating the Limitations of Current BD Therapies
MinuteCE®Navigating the Limitations of Current BD Therapies
Industry Feature

Treatment Considerations in Ulcerative Colitis: Shared Decision-Making
Medical Industry FeatureTreatment Considerations in Ulcerative Colitis: Shared Decision-Making

Quick Takes in ATTR-CM: Diagnosis Barriers
Medical Industry FeatureQuick Takes in ATTR-CM: Diagnosis Barriers

All-Oral Regimen for AML Provides New Treatment Pathway
Medical Industry FeatureAll-Oral Regimen for AML Provides New Treatment Pathway

What Is on the ‘HERIZON’ in 1L HER2+ Gastroesophageal Adenocarcinoma?
Medical Industry FeatureWhat Is on the ‘HERIZON’ in 1L HER2+ Gastroesophageal Adenocarcinoma?

A Real-World CIDP Patient Journey: Perspectives From a Neuromuscular Specialist
Medical Industry FeatureA Real-World CIDP Patient Journey: Perspectives From a Neuromuscular Specialist

Applying a “Do No Harm” Mindset to Moderate-to-Severe Plaque Psoriasis Treatment Selection
Medical Industry FeatureApplying a “Do No Harm” Mindset to Moderate-to-Severe Plaque Psoriasis Treatment Selection
























































































































